PHARMACITY BELGIUM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACITY BELGIUM
Largest movements
- Current investments -€402,440
down €402,440 (-67.1%), from €600,000 to €197,560
- Cash -€108,440
down €108,440 (-26.0%), from €417,136 to €308,696
mainly Contributions, distributions and other (-€901,580) and Investment in fixed assets (net) (-€127,083)
- Receivables within one year +€54,282
up €54,282 (+27.3%), from €198,943 to €253,226
of which Trade receivables: +€36,183
- Stocks and contracts -€48,069
down €48,069 (-6.0%), from €798,967 to €750,897
- Tangible fixed assets +€32,289
up €32,289 (+15.1%), from €213,215 to €245,504
of which Other tangible fixed assets: +€27,692
- Profit (loss) carried forward -€469,607
down €469,607 (-100%), from €469,607 to €0
- Other debts +€161,630
up €161,630 (+47.2%), from €342,429 to €504,059
- Debts after one year -€107,736
down €107,736 (-30.4%), from €354,863 to €247,127
- Reserves -€87,627
down €87,627 (-18.0%), from €485,992 to €398,365
of which Distributable reserves: -€85,767
- Trade debts +€68,560
up €68,560 (+34.3%), from €199,628 to €268,188
- Gross operating margin -€71,840
down €71,840 (-4.3%), from €1.7m to €1.6m
- Staff costs +€52,430
up €52,430 (+5.5%), from €951,355 to €1.0m
- Taxes -€45,605
down €45,605 (-29.6%), from €154,300 to €108,694
- Depreciation +€40,438
up €40,438 (+74.4%), from €54,357 to €94,794
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,293,049 | €1,819,571 | -€473,478 | -20.6% |
| Fixed assets | 21/28 | €263,223 | €295,512 | +€32,289 | +12.3% |
| Tangible fixed assets | 22/27 | €213,215 | €245,504 | +€32,289 | +15.1% |
| Furniture and vehicles | 24 | €20,298 | €24,894 | +€4,597 | +22.6% |
| Other tangible fixed assets | 26 | €192,917 | €220,610 | +€27,692 | +14.4% |
| Financial fixed assets | 28 | €50,008 | €50,008 | = | 0.0% |
| Current assets | 29/58 | €2,029,826 | €1,524,059 | -€505,767 | -24.9% |
| Stocks and contracts in progress | 3 | €798,967 | €750,897 | -€48,069 | -6.0% |
| Stocks | 30/36 | €798,967 | €750,897 | -€48,069 | -6.0% |
| Amounts receivable within one year | 40/41 | €198,943 | €253,226 | +€54,282 | +27.3% |
| Trade receivables | 40 | €169,231 | €205,413 | +€36,183 | +21.4% |
| Other amounts receivable | 41 | €29,712 | €47,812 | +€18,100 | +60.9% |
| Current investments | 50/53 | €600,000 | €197,560 | -€402,440 | -67.1% |
| Cash at bank and in hand | 54/58 | €417,136 | €308,696 | -€108,440 | -26.0% |
| Deferred charges and accrued income | 490/1 | €14,780 | €13,679 | -€1,101 | -7.4% |
| Total equity and liabilities | 10/49 | €2,293,049 | €1,819,571 | -€473,478 | -20.6% |
| Equity | 10/15 | €974,200 | €416,965 | -€557,235 | -57.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €485,992 | €398,365 | -€87,627 | -18.0% |
| Non-distributable reserves | 130/1 | €1,860 | €0 | -€1,860 | -100% |
| Reserves not available under the articles | 1311 | €1,860 | €0 | -€1,860 | -100% |
| Distributable reserves | 133 | €484,132 | €398,365 | -€85,767 | -17.7% |
| Profit (loss) carried forward | 14 | €469,607 | €0 | -€469,607 | -100% |
| Amounts payable | 17/49 | €1,318,849 | €1,402,605 | +€83,756 | +6.4% |
| Amounts payable after more than one year | 17 | €354,863 | €247,127 | -€107,736 | -30.4% |
| Financial debts | 170/4 | €354,863 | €247,127 | -€107,736 | -30.4% |
| Amounts payable within one year | 42/48 | €959,167 | €1,151,081 | +€191,914 | +20.0% |
| Current portion of amounts payable after more than one year | 42 | €106,466 | €107,736 | +€1,270 | +1.2% |
| Trade debts | 44 | €199,628 | €268,188 | +€68,560 | +34.3% |
| Suppliers | 440/4 | €199,628 | €268,188 | +€68,560 | +34.3% |
| Taxes, remuneration and social security | 45 | €310,645 | €271,099 | -€39,546 | -12.7% |
| Taxes | 450/3 | €79,395 | €45,063 | -€34,332 | -43.2% |
| Remuneration and social security | 454/9 | €231,249 | €226,036 | -€5,213 | -2.3% |
| Other amounts payable | 47/48 | €342,429 | €504,059 | +€161,630 | +47.2% |
| Accrued charges and deferred income | 492/3 | €4,819 | €4,397 | -€422 | -8.8% |
| Remuneration, social security and pensions | 62 | €951,355 | €1,003,785 | +€52,430 | +5.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €54,357 | €94,794 | +€40,438 | +74.4% |
| Other operating charges | 640/8 | €22,932 | €28,063 | +€5,132 | +22.4% |
| Gross operating margin | 9900 | €1,652,397 | €1,580,557 | -€71,840 | -4.3% |
| Operating profit (loss) | 9901 | €623,753 | €453,915 | -€169,839 | -27.2% |
| Financial income | 75/76B | €10,424 | €17,878 | +€7,454 | +71.5% |
| Recurring financial income | 75 | €10,424 | €17,878 | +€7,454 | +71.5% |
| Financial charges | 65/66B | €10,270 | €18,752 | +€8,482 | +82.6% |
| Recurring financial charges | 65 | €10,270 | €18,752 | +€8,482 | +82.6% |
| Profit (loss) for the period before taxes | 9903 | €623,907 | €453,040 | -€170,867 | -27.4% |
| Income taxes | 67/77 | €154,300 | €108,694 | -€45,605 | -29.6% |
| Profit (loss) for the period | 9904 | €469,607 | €344,346 | -€125,261 | -26.7% |
| Profit (loss) for the period to be appropriated | 9905 | €469,607 | €344,346 | -€125,261 | -26.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.